Taiwan Over the Counter Drugs Market by Formulation type - (Tablets, Liquids, Ointments, Sprays) by Product type - (Cough and cold Flu drugs, Analgesics, Dermatologics, Gastrointestinal Drugs, Antiseptics, Anti-allergy drugs, Smoking Cessation Aids, Vitamins and Minerals, Ophthalmics, Sleep aids, weight loss/Diet drugs, others(Ear Drops & Diuretics)), by distribution - (Pharmacies/Drug Stores, Super markets/Hyper markets, convenience stores, others) by Region – Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Taiwan Over the Counter Drugs Market by Formulation type - (Tablets, Liquids, Ointments, Sprays) by Product type - (Cough and cold Flu drugs, Analgesics, Dermatologics, Gastrointestinal Drugs, Antiseptics, Anti-allergy drugs, Smoking Cessation Aids, Vitamins and Minerals, Ophthalmics, Sleep aids, weight loss/Diet drugs, others(Ear Drops & Diuretics)), by distribution - (Pharmacies/Drug Stores, Super markets/Hyper markets, convenience stores, others) by Region – Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 803 | Pages: 135 | October 2016 | Region: Taiwan


The Taiwan Over the Counter Drugs Market was worth USD 1.80 billion in 2016 and estimated to reach USD 2.39 billion by the end of 2021 with a growing potential of 5.82%. Taiwan Over the Counter Drugs market accounts for 3.5% of total Asia-Pacific OTC market

The term ‘’Over the counter’’ mentions to pharmaceuticals, which are bought across the counter without any need of physicians’ prescription. OTC drugs are used to treat and prevent minor disorders, as growing aging population there is an increasing push to be able to license OTC medicines for the use of treatment of chronic conditions. The aging population (>65) accounts for 11.4% of total population in Taiwan.

The government has reduced tax for the pharmaceutical industry as an encouragement to many foreign multinational companies to invest in Taiwan. The government has recently made 13 prescription drugs available over the counter, making a purchase of the drugs more convenient. However, the government has also cut the price of drugs funded under the national health programmes.

The Taiwan OTC pharmaceutical market is driven by factors such as lower costs compared to Prescription drugs, growing preference of using OTC drugs for minor ailments, increased health care expenditure, Government policies like healthcare infrastructure, insurance system. Cost sensitivity of production is the major factor inhibiting the growth of the market.

The Taiwan OTC Pharmaceutical Market is broadly categorized by Formulation type - Tablets, Liquids, Ointments, Sprays, by Product type - Cough and cold Flu drugs, Analgesics, Dermatologics, Gastrointestinal Drugs, Antiseptics, Anti-allergy drugs, Smoking Cessation Aids, Vitamins and Minerals, Ophthalmics, sleep aids, Weightloss/diet drugs and others(Ear Drops & Diuretics), by distribution channels - Pharmacies/Drug Stores, Supermarkets/Hypermarkets, convenience stores, others ( online drug stores ).

Some of the key players dominating the Over the Counter Drugs market in Taiwan are Johnson & Johnson, Sinphar pharmaceutical co ltd, China Chemical & Pharmaceutical Co., Ltd, Daiichi Sankyo Co,. ltd, Glaxo smithkline, Bayer Health care, Merck Ltd, Novartis.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Formulation Type                              

                                5.1.1 Tablets      

                                5.1.2 Liquids      

                                5.1.3 Ointments               

                                5.1.4 Sprays       

                5.2 By Product Type                       

                                5.2.1 Cough, Cold and Flu Drugs

                                5.2.2 Analgesics

                                5.2.3 Dermatologicals    

                                5.2.4 Gastrointestinal Drugs

                                5.2.5 Antiseptics              

                                5.2.6 Anti-Allergy Drugs

                                5.2.7 Smoking Cessation Aids     

                                5.2.8 Ophthalmic Drugs

                                5.2.9 Vitamins and Minerals       

                                5.2.10 Sleep Aids             

                                5.2.11 Weight Loss/Diet Products            

                                5.2.12 Others (Ear Drops & Diuretics)     

                5.3 By Distribution Channel                         

                                5.3.1 Pharmacies/Drugstores     

                                5.3.2 Supermarkets/Hypermarkets         

                                5.3.3 Convenience stores            

                                5.3.4 Others (Online Drugstores)             

6. Strategic Analysis                                       

                6.1 PESTLE analysis                         

                                6.1.1 Political     

                                6.1.2 Economic 

                                6.1.3 Social         

                                6.1.4 Technological         

                                6.1.5 Legal          

                                6.1.6 Environmental       

                6.2 Porter’s Five analysis                              

                                6.2.1 Bargaining Power of Suppliers        

                                6.2.2 Bargaining Power of Consumers    

                                6.2.3 Threat of New Entrants     

                                6.2.4 Threat of Substitute Products and Services              

                                6.2.5 Competitive Rivalry within the Industry     

7. Market Leaders' Analysis                                        

                7.1 Johnson & Johnson                 

                                7.1.1 Overview 

                                7.1.2 Product Analysis   

                                7.1.3 Strategic Evaluation and Operations            

                                7.1.4 Financial analysis  

                                7.1.5 Legal issues             

                                7.1.6 Recent Developments       

                                7.1.7 SWOT analysis       

                                7.1.8 Analyst View          

                7.2 Sinphar pharmaceutical co ltd                             

                7.3 China Chemical & Pharmaceutical Co., Ltd                     

                7.4 GlaxoSmithKline Plc                                

                7.5 Daiichi Sankyo Co,. Ltd                           

                7.6 Bayer Health care                    

                7.7 Merck Ltd                    

                7.8 Novartis                       

8. Competitive Landscape                                           

                8.1 Market share analysis                            

                8.2 Merger and Acquisition Analysis                       

                8.3 Agreements, collaborations and Joint Ventures                         

                8.4 New Product Launches                         

9. Expert Opinions                                          

                9.1 Market Outlook                        

                9.2 Investment Opportunities                   

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

TitlePriceAdd To Cart

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, kakatiya's empire,
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.